NASDAQ:NCTY

The9 Stock Forecast, Price & News

$11.95
-0.30 (-2.45 %)
(As of 09/16/2021 02:10 PM ET)
Add
Compare
Today's Range
$11.85
$12.28
50-Day Range
$8.68
$16.86
52-Week Range
$2.04
$89.20
Volume12,613 shs
Average Volume3.55 million shs
Market Capitalization$224.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.16
30 days | 90 days | 365 days | Advanced Chart
Receive NCTY News and Ratings via Email

Sign-up to receive the latest news and ratings for The9 and its competitors with MarketBeat's FREE daily newsletter.


The9 logo

About The9

The9 Ltd. engages in the operation of online games. It operates through Greater China and Other Areas geographical segments. The firm is transitioning to cryptocurrencies mining business. The company was founded by Jun Zhu on December 22, 1999 and is headquartered in Shanghai, China.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.24 out of 5 stars

Computer And Technology Sector

736th out of 858 stocks

Business Services, Not Elsewhere Classified Industry

113th out of 134 stocks

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











The9 (NASDAQ:NCTY) Frequently Asked Questions

What stocks does MarketBeat like better than The9?

Wall Street analysts have given The9 a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The9 wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting The9?

The9 saw a increase in short interest in July. As of July 30th, there was short interest totaling 1,190,000 shares, an increase of 14.4% from the July 15th total of 1,040,000 shares. Based on an average daily volume of 3,150,000 shares, the short-interest ratio is presently 0.4 days. Approximately 10.5% of the shares of the stock are sold short.
View The9's Short Interest
.

How has The9's stock been impacted by COVID-19 (Coronavirus)?

The9's stock was trading at $6.3870 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NCTY stock has increased by 89.6% and is now trading at $12.11.
View which stocks have been most impacted by COVID-19
.

When did The9's stock split? How did The9's stock split work?

Shares of The9 reverse split on Monday, October 19th 2020. The 1-10 reverse split was announced on Tuesday, October 13th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 16th 2020. An investor that had 100 shares of The9 stock prior to the reverse split would have 10 shares after the split.

Who are The9's key executives?

The9's management team includes the following people:
  • Jun Zhu, Chairman & Chief Executive Officer
  • Guo Ding Shen, President
  • Kwok Ho Lai, Chief Financial Officer & Director
  • Connie Sun, Investor Relations Specialist

Who are some of The9's key competitors?

What other stocks do shareholders of The9 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The9 investors own include Amarin (AMRN), Gevo (GEVO), Biocept (BIOC), Nabriva Therapeutics (NBRV), Occidental Petroleum (OXY), Acasti Pharma (ACST), Anavex Life Sciences (AVXL), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and Jaguar Health (JAGX).

What is The9's stock symbol?

The9 trades on the NASDAQ under the ticker symbol "NCTY."

Who are The9's major shareholders?

The9's stock is owned by many different retail and institutional investors. Top institutional investors include Susquehanna International Group LLP (0.00%), Carmignac Gestion (0.56%), Citigroup Inc. (0.39%), Wolverine Trading LLC (0.00%), Citadel Advisors LLC (0.00%) and Cutler Group LP (0.00%).

Which institutional investors are selling The9 stock?

NCTY stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.

Which institutional investors are buying The9 stock?

NCTY stock was purchased by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP, Citigroup Inc., Paloma Partners Management Co, Morgan Stanley, Morgan Stanley, SG Americas Securities LLC, Wolverine Trading LLC, and Group One Trading L.P..

How do I buy shares of The9?

Shares of NCTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is The9's stock price today?

One share of NCTY stock can currently be purchased for approximately $12.11.

How much money does The9 make?

The9 has a market capitalization of $227.45 million and generates $100,000.00 in revenue each year.

How many employees does The9 have?

The9 employs 105 workers across the globe.

What is The9's official website?

The official website for The9 is www.the9.com.

Where are The9's headquarters?

The9 is headquartered at BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203.

How can I contact The9?

The9's mailing address is BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203. The technology company can be reached via phone at 862161086080 or via email at [email protected]


This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.